Tag: Immune Disorders

MI outcomes poorer in Medicare beneficiaries with versus without rheumatic immune-mediated inflammatory disease

Risk increased progressively with the number of autoimmune diseases present and with younger age

Guidelines expand indications for some vaccines and provide guidance on medication management at time of vaccination

Local and systemic reactions reported less frequently after fourth dose versus dose 3 of primary vaccination series

Immunocompromised patients have increased odds of ICU admission, in-hospital death, regardless of vaccination status

Patients with rs2814778-CC also have lower last leukocyte count and lower dosing; findings persist after adjustment for race

Findings seen in immunosuppressed patients with rheumatic and musculoskeletal diseases, solid organ transplant recipients

Odds ratios for GBS were highest for cancers of lymphatic and hematopoietic tissue, respiratory tract, prostate, breast

Subgroup analysis performed for patients with autoimmune disease-related progressive fibrosing interstitial lung diseases

Study authors suggest future research assess the potential benefits of screening COVID-19 patients for antiphospholipids and other autoantibodies